Revalesio Corporation   Report issue

For profit Phase 1 Phase 2
Founded: Tacoma WA United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2010
NCT01057498
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Revalesio Corporation